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Abstract
 .  .The exposure of confluent peritubular PT cells from immature rat testis to insulin-like growth factor-1 IGF-1 induced
w35 x w3 xa time and dose-dependent increase of S -sulfate and H -D-glucosamine incorporations in newly synthesized proteogly-
 .cans PG . This increased content of PG was the result of an enhancement of PG synthesis rather than a decreased rate of
degradation. IGF-1 had no effect on the molecular weight of synthesized PG nor on the nature and distribution of the
constitutive glycosaminoglycan chains, both in medium and in cell layer. The stimulation of PG synthesis by IGF-1
appeared to be due, at least partially, to an increase of glycosylation processes. IGF-1 effect was mediated by the classical
tyrosine kinase signalling process, since IGF-1 action on PG synthesis was abolished by genistein and tyrphostin A9, two
well known tyrosine kinase inhibitors. The increase of PG synthesis was accompanied with an undersulfation of constitutive
 .  . w35 x w3 xglycosaminoglycan GAG chains chondroitin sulfate and heparan sulfate chains since the S r H ratio was reduced by
about 20–25% in presence of IGF-1. Although the mechanism of hyaluronic acid synthesis was completely different from
those of other GAG, IGF-1 also dramatically enhanced its production by PT cells. q 1997 Elsevier Science B.V.
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1. Introduction
In the testis, peritubular cells are a mesenchymal
cell type that surround the seminiferous tubule adja-
cent to the basal surface of the Sertoli cells and these
two cells are separated by a basement membrane.
One important peritubular cell function is to provide
structural support for the seminiferous tubule and
)  .Corresponding author. Fax: q33 2 31565320.
help to maintain the proper cytoarchitecture of the
w xepithelium 1 . In this view, both peritubular and
Sertoli cells cooperate in the production of compo-
 .nents of the extracellular matrix ECM and forma-
w xtion of the basement membrane 2 . This cooperation
requires an exchange of information between the two
cell types which may occur through soluble factors
w xand through proteoglycan participation 3 .
 .Proteoglycans PG are important constituents of
 .the extracellular matrix ECM ; they are necessary
for stable assembly of this matrix and functional
w xcell–ECM interactions 4 . In addition to the extracel-
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lular matrix, one other major area in which the
proteoglycans are widely distributed is the cell mem-
brane. A growing body of evidence suggests that
cell-associated proteoglycans and particularly proteo-
heparans, play an important role in the control of
cell–cell and cell–matrix interactions acting upon
tissue architecture and morphogenesis, cell adhesion
w xand migration 5 .
Soluble factors have been shown to potentially
mediate regulatory interactions between peritubular
cells and Sertoli cells. The non-mitogenic peptide
P-Mod-S, secreted by peritubular cells modulates Ser-
w xtoli cell functions 6 . Additional soluble factors that
have been identified are growth factors. Testicular
somatic and germinal cells may be the site of produc-
tion and the target of several growth factors which
are thought to have a local action by autocrine or
w xparacrine mechanisms 7 . For example, rat Sertoli
w xcells 8 were shown to secrete a peptide identical to
IGF-1 and to possess specific membrane receptors for
w xIGF-1 9 . Moreover, Leydig cells and peritubular
w xcells 8 from immature rats also secrete IGF-1. Thus,
IGF-1 is ubiquitously produced in the testis.
IGF-1 has been reported to stimulate the PG syn-
thesis in several cell types. IGF-1 effects on articular
cartilage have received much attention and are now
w35 xwell documented. For example, the S -sulfate in-
corporation in aggrecan is stimulated by IGF-1 in
chondrocyte cultures and the synthesis of large PG is
w xmaintained by IGF-1 10 .
Taking into account the importance of the PG in
cell–cell and cell–ECM interactions, we have shown
in a previous work that peritubular cells synthesize
PG which are membrane-associated and also con-
w xstituents of the ECM 11 . In the present work, we
have examined the effects of IGF-1 on the synthesis
of PG by testicular peritubular cells isolated from
immature rats. The hydrodynamic size of the differ-
ent populations of PG, the GAG chain lengths and
the nature of these PG have been analyzed in pres-
ence of IGF-1.
IGF-1 signal transmission pathways are now well
documented and it is known that IGF-1 acts through
w xthe tyrosine kinase activity of its receptor 12 . Ac-
cordingly, we have studied the putative involvement
of this transduction system in the expression of the
IGF-1 effects on PG synthesis, by using two tyrosine
 .kinase inhibitors genistein and tyrphostin .
2. Materials and methods
2.1. Materials
Sprague–Dawley rats were obtained from our own
 .colony. Phosphate buffered saline PBS , Dulbecco’s
 .modified Eagle’s medium DMEM , HAM’s F12
 .medium and trypsin USP Grade for cell culture
 .were from Gibco-BRL Cergy-Pontoise, France .
 .Collagenase-dispase, fetal calf serum FCS and IGF-
 .1 were from Boehringer-Mannheim Meylan, France .
 .Bovine pancreas deoxyribonuclease I DNAse I , tes-
 .ticular hyaluronidase type I-S , trypsin inhibitor, Tri-
ton X-100, chondroitinase ABC, para-nitrophenyl-b-
 .D-xyloside PNPX , para-nitrophenyl-b-D-galacto-
 .  .side PNPG and cycloheximide CHX were pur-
 .chased from Sigma Saint-Quentin-Fallavier, France .
w35 x  . w3 xS -sulfate 39–59 TBqrmmol and H -D-gluco-
 .samine hydrochloride 1.2 TBqrmmol were pur-
 .chased from NEN Les Ulis, France . Genistein,
daidzein and tyrphostins A1 and A9 were from Cal-
biochem and France-Biochem and Streptomyces
hyaluronidase was from Calbiochem Meudon,
.France . DEAE-Trisacryl was provided by IBF-Bio-
 .technics Villeneuve-la-Garenne, France . Superose 6
was obtained from Pharmacia Saint-Quentin- en
.  .Yvelynes, France . Cationic nylon Zeta-Probe and
the microfold dot blot apparatus were from Bio-Rad
 .Ivry-sur-Seine, France .
2.2. Cell cultures
Peritubular cells were isolated from the testes of
18–20 day-old rats by sequential enzymatic diges-
w xtions at 328C as previously described 13 . Briefly,
decapsulated testes were treated with trypsin 1
.  .mgrml and DNAse 0.02 mgrml in HAM
 .F12rDMEM 1:1 vrv; HrD containing bicarbonate
 . 2.2 grl and antibiotics 50 IUrml penicillin, 50
mgrml streptomycin, 50 mgrml kanamycine, 0.25
.mgrml fungizone for 25 min at 328C. After addition
 .of soybean trypsin inhibitor 0.1 mgrml , interstitial
cells were discarded and seminiferous tubules were
washed three times with HrD, then submitted to
digestion by a mixture of collagenase–dispase 1
.  .mgrml and testicular hyaluronidase 2 mgrml for
25 min at 328C. After unit-gravity sedimentation 5
.min , peritubular cells in the supernatant were recov-
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 .ered by centrifugation 800=g for 10 min washed
twice with HrD and resuspended in HrD containing
10% FCS; the cells were then plated onto 75 cm2
plastic flasks at a density of 30 000 cellsrcm2. The
cells were maintained in a humidified atmosphere
containing 5% CO , at 328C. Culture medium was2
changed every 2 days and peritubular cells were
grown to confluence. Confluent cultures were
 .trypsinized 0.25% trypsin in PBS plus 0.02% EDTA
and replated at a density of 30 000 cellsrcm2 in
either 24 wells or 75 cm2 plastic flasks depending
upon the experiments. At confluence, cells were incu-
bated in HrD without FCS, 24 h prior to radiolabel-
ing.
2.3. Determination of PG and GAG synthesis
Confluent monolayers were double labeled in
w35 xserum free HrD containing carrier free S -sulfate
 . w3 x0.37 MBqrml or 10 mCirml and H -D-gluco-
 .samine 0.07 MBqrml or 2 mCirml for 24 h, in
presence or in absence of agents mentioned below.
After labeling, the culture medium was collected, the
cell layer was washed three times with PBS. The
medium and PBS were centrifuged 800=g for 30
.min . To the supernatant an equal volume of Tris–HCl
buffer 100 mM Tris, pH 7.2, containing 8 M urea,
 .1% Triton X-100 v:v and a mixture of protease
inhibitors: 20 mM EDTA, 200 mM 6-aminohexanoic
acid, 10 mM benzamidine-HCl, 2 mgrml pepstatin,
20 mM N-ethyl-maleimide, 0.4 mM phenylmethyl-
. sulfonide fluoride TUT buffer at double concentra-
.tion was added. The cell layer was solubilized with
the same buffer, under gentle shaking for 24 h at 48C,
boiled for 3 min and cleared by centrifugation 800
.=g, 30 min .
The quantification of PG from the medium and
cell layer extract was determined by slightly modified
solid phase assay using cationic nylon membrane
w x14 . Samples prepared as indicated above were spot-
ted on a membrane previously soaked for 30 min in
 .50 mM Tris–HCl, 0.15 M NaCl, pH 7.0 TBS and
sandwiched in a 96-well dot blot apparatus. The
membrane was successively washed for 1 h with TBS
containing 0.15 M NaCl then with TBS composed of
NaCl 0.9 M, to remove free GAG, then rinsed with
distilled water and ethanol. Spots were cut and their
radioactivity was determined by scintillation count-
ing. The radioactivity in the 0.15 M NaCl-treated dot
represented the radioactivity incorporated in PG-asso-
ciated or free GAG chainsrfragments whereas ra-
dioactivity measured in the 0.9 M NaCl-treated dot
represented only the radioactivity incorporated in
PG-associated GAG chains. For each culture well,
radioactivity incorporated in free GAG chains was
determined by subtracting the radioactivity of the
0.15 M treated dot from that of the 0.9 M treated dot.
To assess the effects of IGF-1 on GAG synthesis,
cell cultures were treated with 1 mM para-
 .nitrophenyl-b-D-xyloside PNPX for 24 h, in the
presence or absence of IGF-1. PNPX-GAG and resid-
w3 xual PG were radiolabeled with H -glucosamine and
their synthesis was determined as described above.
2.4. Pulse–chase experiment
The effect of IGF-1 on proteoglycan degradation
in peritubular cells was investigated by pulse–chase
experiments. Confluent peritubular cells in 24-well
culture dishes were radiolabeled with 10 mCirml
w35 x w3 xS -sulfate and 2 mCirml H -D-glucosamine for
24 h at 328C. The medium was then removed and the
cell layer was extensively washed with HrD to re-
move free labeled precursors. Separated wells were
then ‘chased’ for 6.5 to 24 h, either in the presence or
absence of IGF-1 at a 50 ngrml concentration. After
 .each ‘chase’ period 6.5, 12 and 24 h , the proteogly-
cans in the medium and extracted from the cell layer
were quantified on the Zeta-probe membrane.
2.5. Analysis of proteoglycans and hyaluronic acid
Double labeled proteoglycans were first purified
by anion-exchange chromatography. The medium or
the cell extracts were dialysed against TUT buffer.
The samples were applied to a DEAE-Trisacryl col-
 .umn 1=5 cm previously equilibrated with TUT
buffer. Elution was performed with 10 ml of TUT
 .buffer, then with a linear gradient of NaCl 0–1.2 M
in the same buffer. A flow rate of 15 mlrh was used
and 1 ml fractions were collected. The fractions
corresponding to the peak of PG and GAG material
.eluted between 0.4–0.5 M NaCl were pooled and
precipitated with ethanol. The pellet was redissolved
in distilled water, aliquoted, lyophilized and samples
were reconstituted with different buffers depending
upon the subsequent treatments.
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An aliquot of PG was dissolved in TUT buffer,
 .cleared by centrifugation 10 000=g for 10 min and
then submitted to gel filtration on a Superose 6
 .column 1=30 cm . The elution was carried out with
TUT buffer at a flow rate of 12 mlrh and 0.4 ml
fractions were collected.
Lyophilized PG were then submitted to b-elimina-
tion in the presence of 0.05 M NaOH and 1 M
w xNaBH 15 . After 48 h incubation at 458C, the4
mixture was neutralized with glacial acetic acid and
precipitated with ethanol. The pellet was dissolved in
 .TUT buffer and centrifuged 10 000=g for 10 min
prior to chromatography on a Superose 6 column as
indicated above.
Heparan side chains were degraded by deaminative
w xcleavage using the pH 1.5rHNO method 16 .2
Chondroitin sulfate chains were digested with chon-
 .droitinase ABC 1 IUrml in 50 mM Tris–HCl
Fig. 1. Dose related and time course effects of IGF-1 on proteoglycan biosynthesis. Peritubular cells were cultured in serum-free medium
w35 x w3 x24 h prior to the experiments, then incubated in the same medium containing S -sulfate and H -glucosamine, in the presence or
 .absence of IGF-1. Double labeled secreted and cell layer associated PG were quantified as described in Section 2. A and B Dose related
w35 x  . w3 x  .effect of IGF-1. S -sulfate -‘-‘- and H -glucosamine -v-v- incorporations were performed for 24 h, in the presence of
 .  .  .increasing concentrations of IGF-1 0–100 ngrml . Radioactivities of PG from medium A and cell layer B were expressed as
 .percentage of their respective mean basal value. C and D Time course effect of IGF-1. Cells were cultured during indicated
 . w35 x  . .time-periods, in the absence or presence 50 ngr ml of IGF-1, labeled with S -sulfate C -‘-‘-, control; -I-I-, IGF-1 and
w3 x  . .  .H -glucosamine D -v-v-, control; -B-B-, IGF-1 . Total PG mediumqcell layer were quantified. Values are means"SEM from
4 wells in 3 separated experiments. )P-0.05, ))P-0.01, )))P-0.001 when compared to their respective control.
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 .buffer pH 8.0 containing 60 mM sodium acetate, 50
mM NaCl, 1 mM NaF, 0.1 mgrml bovine serum
w xalbumin 17 .
Hyaluronic acid was degraded by Streptomyces
 .hyaluronidase 2 UIrml in 0.02 M acetate buffer,
w xpH 5, for 24 h at 378C 18 .
In all cases, the degradation extent of polysaccha-
rides was determined by Superose 6 chromatography.
2.6. General techniques
The viability of peritubular cells was assessed by
the trypan blue dye exclusion test and was never
below 98%. The purity of peritubular cell cultures
was determined using histochemical markers for per-
 . w xitubular cells alkaline phosphatase 19 , Leydig cells
 . w x3b-hydroxysteroid dehydrogenase 20 or Sertoli
 .cells staining neutral lipid droplets with Oil Red O
w x21 . The Leydig cell marker was not detected in any
of the cultures and Sertoli cells represented less than
5% of the total cell population. The purity of the
peritubular cell cultures thus reached at least 95%.
DNA content of cells was determined fluorimetri-
cally using Hoechst 33258 reagent according to West
w xand al. 22 .
2.7. Statistical analysis
All experimental data were presented as the mean
"SEM of four independent incubations and each
experiment was repeated at least three times.
Statistical significance between groups were deter-
mined by the Student’s t-test using the Statworks
package on a Macintosh computer Apple Computer,
.Cupertino, CA . Differences were considered signifi-
cant at P-0.05.
3. Results
3.1. Dose related and time course effects of IGF-1 on
[35 ] [3 ]S -sulfate and H -D-glucosamine incorporations
in proteoglycans
IGF-1 had an optimal stimulatory effect on PG
synthesis for a 50 ngrml concentration and no addi-
tional effect was observed when IGF-1 was used at
100 ngrml. In the presence of 50 ngrml IGF-1, the
w35 x w3 xincorporations of S -sulfate and of H -D-gluco-
samine were significantly increased by 13 and 23%
 .into secreted PG Fig. 1A and by 20 and 30% in
 .cell-associated PG Fig. 1B , respectively. Although
peritubular cells were confluent, we examined the
possibility that IGF-1 induced stimulation of the PG
synthesis may be due to an increase of cell prolifera-
tion. However, the DNA content was not modified by
 .IGF-1 50 ngrml in our experimental conditions
control: 582"21 ng DNArwell, IGF-1 treatment:
.576"20 ng DNArwell .
Treatment of the peritubular cells with IGF-1 50
w35 x  . w3 x  .Fig. 2. Pulse–chase experiments. Cell cultures were labeled with S -sulfate A and H -glucosamine B for 24 h. The medium was
 .discarded, the cell layer was washed and cell culture was ‘chased’ for various times, either in the absence control or presence of IGF-1
 .  .  .qIGF-1, 50 ngrml . For each time, PG associated to the cell layer CL and released into the culture medium M were quantified.
Values are means"SEM from 3 separated experiments.
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.ngrml generated time-dependent increases in the
total proteoglycan biosynthesis. The stimulations were
maximal after 24 h of incubation q20% and q30%
w35 x  . w3 xfor S -sulfate Fig. 1C and H -D-glucosamine
 . .Fig. 1D incorporations, respectively . Beyond a 24
h period of incubation, the stimulatory effects of
IGF-1 were less pronounced, since after 48 h treat-
w35 x w3 xment, S and H radioactivities were only in-
creased by 11 and 18%, respectively.
3.2. Pulse–chase studies
Treatment of pulse-labeled cell cultures with IGF-1
during the chase period did not affect significantly
the rate of PG disappearance from the cell layer. The
rate of PG loss corresponded to an apparent t of1r2
11 and 24 h when calculated after prelabeling with
w35 x  . w3 x S -sulfate Fig. 2A and H -D-glucosamine Fig.
. w3 x w35 x2B , respectively. H and S PG radioactivity
was also determined in the chase medium. The results
w3 xshowed that H -PG radioactivity released from the
cell layer was completely recovered in the culture
 .medium Fig. 2B . On the contrary, after 24 h of
w35 xchase, the S PG radioactivity determined in the
medium was less than that released from the cell
 . w35 xlayer Fig. 2A . This difference suggested that S -
PG, during their transfer from cell to medium, may
be partially desulfated. IGF-1 had no additional influ-
ence on this process.
 .  .Fig. 3. DEAE-Trisacryl chromatography of culture medium A and B and cell layer extract C and D . Cell cultures were incubated
 .  .  . w35 x  .without A and C or with IGF-1 50 ngrml B and D and simultaneously labeled for 24 h with S -sulfate -‘-‘- and
w3 x  .H -glucosamine -v-v- . Medium and cell layer extract were applied to a DEAE-Trisacryl column and eluted with a 0–1.2 M NaCl
 .gradient solid line .
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3.3. Characterization of proteoglycans and hyaluronic
acid synthesized in presence of IGF-1
After labeling for 24 h, secreted material was
 .purified by ion-exchange chromatography Fig. 3 .
 .The elution profile of the control Fig. 3A and IGF-1
 .treated media Fig. 3B showed two peaks. The first
 .peak peak I-M , eluted in the gradient at 0.2 M
w3 x NaCl, was only labeled with H -glucosamine Fig.
.3A . When submitted to Superose 6 chromatography,
peak I-M emerged in the excluded volume and this
peak was entirely susceptible to digestion by Strepto-
 . w3 xmyces hyaluronidase Fig. 4A . Thus, H -labeled
molecules from peak I-M corresponded to large
molecular-weight hyaluronic acid. Addition of IGF-1
to peritubular cell cultures induced about a two fold
increase of hyaluronic acid synthesis Fig. 3B and
.Fig. 4B .
 . w3 x w35 xA second peak peak II-M , H - and S -double
labeled, emerged from the DEAE- Trisacryl column
at 0.55 M NaCl concentration for control medium
 .Fig. 3A and at 0.44 M NaCl for IGF-1 treated
 . medium Fig. 3B . Peak II-M contained PG see
.below . PG synthesized in the presence of IGF-1 had
a lower charge density than those originating from
control cultures. This observation was confirmed by
w35 x w3 xthe values of the S r H ratio that were 3.65 and
3 for control and IGF-1 treated cultures, respectively.
Thus, IGF-1 induced a 18% decrease in the relative
w35 xS -sulfate incorporation. The fractions of peak II-M
were pooled, concentrated and submitted to gel filtra-
Table 1
Distribution and sulfation level of proteochondroitin sulfate
 .  .CSPG and proteoheparan sulfate HSPG in control and IGF-1
treated peritubular cell cultures
CSPG HSPG
a .Distribution CSPGrHSPG %
Medium control 85"4.4 15"4.0
IGF-1 83"8.3 17"5.2
Cell layer control 23"3.7 77"5.5
IGF-1 20"4.8 80"7.3
bSulfation level
Medium control 5.5"0.4 3.1"0.2
IGF-1 3.6"0.5 2.2"0.3
Cell layer control 4.5"0.2 3.7"0.2
IGF-1 3.7"0.3 2.8"0.1
a Values are expressed as a percentage of total PG CSPGq
.HSPG present in the medium or in the cell layer. The distribu-
tion percentages were calculated from results obtained after
w3 xSuperose 6 chromatography of H -labeled PG from peak II-M
 .  .medium or peak II-CL-a cell layer submitted to digestion by
chondroitinase ABC or to degradation by nitrous acid see Fig.
.5C–F for peak II-M, Fig. 7A–D for peak II-CL-1 .
b w35 x w3 xThe sulfation level was evaluated by the S r H ratio
calculated from each species of PG which was distinguished as
indicated in a.
Each value represents mean"SEM for 3 determinations.
 .tion on a Superose 6 column Fig. 5A and B . PG
from control medium were eluted at K s0.12 in aav
 .homogenous peak Fig. 5A . The elution profile of
PG secreted in the presence of IGF-1 was similar
 .Fig. 5B . After digestion of peak II-M with chon-
 . Fig. 4. Gel filtration chromatography of DEAE-Trisacryl purified peak I-M on Superose-6. Peak I-M from control A or IGF-1 50
.  .  .  .ngrml conditioned medium B was chromatographed before -v-v- or after Streptomyces hyaluronidase digestion -B-B- .
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 . Fig. 5. Gel filtration chromatography of DEAE-Trisacryl purified peak II-M Fig. 3A and B on Superose-6. Peak II-M from control A,
.  .  .  .C and E or IGF-1 50 ngrml conditioned medium B, D and F was chromatographed without prior treatment A and B , after
 .  .  . w35 x  . w3 xchondroitinase ABC digestion C and D or after nitrous acid degradation E and F . -‘-‘- : S radioactivity. -v-v- : H
radioactivity.
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w35 xdroitinase ABC, about 85% of S -labeled PG pre-
 .sent in the control Fig. 5C and in IGF-1 treated
 .Fig. 5D cell culture media eluted in the total vol-
ume. In both cases, the chondroitinase ABC-resistant
material was susceptible to nitrous acid degradation
 .Fig. 5E and F . These results indicated that PG in
the medium were predominantly chondroitin
sulfaterdermatan sulfate proteoglycans, containing a
 .minor fraction of heparan sulfate 15% and IGF-1
had no effect on the nature and distribution of GAG
 .chains Table 1 . The level of undersulfation induced
w35 x w3 xby IGF-1 was evaluated by the S r H ratio
 .calculated for CSPG proteochondroitin sulfate and
 . HSPG proteoheparan sulfate from the medium Ta-
.ble 1 .
 .The cell layer extracts see Section 2 submitted to
ion exchange chromatography on DEAE Trisacryl
 .Fig. 3C and D , gave similar results to those ob-
tained for medium.
Peak I-CL, only labeled with tritium and eluted
 .with 0.2 M NaCl Fig. 3C , was entirely susceptible
to digestion by Streptomyces hyaluronidase data not
.shown and consisted of hyaluronic acid. IGF-1 had
very little effect on cell-associated hyaluronic acid
 .Fig. 3D since this polysaccharide was translocated
out into the medium immediately after being synthe-
w x w35 x w3 xsized 23 . Peak II-CL, S r H double labeled
was eluted from the column with 0.57 and 0.53 M
 . NaCl for the control Fig. 3C and IGF-1 treated Fig.
.3D cells. DEAE Trisacryl purified peak II-CL was
chromatographed on a Superose 6 column Fig. 6A
.and B . The elution profile revealed two peaks, one at
 . Fig. 6. Gel filtration chromatography of DEAE-Trisacryl purified peak II-CL Fig. 3C and D on Superose-6. Peak II-CL from control A
.  .  .  .and C or IGF-1 50 ngrml treated cell layer extract B and D was chromatographed without prior treatment A and B or after
 .  . w35 x  . w3 xb-elimination C and D . -‘-‘- : S radioactivity. -v-v- : H radioactivity.
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 .K s0 II-CL-a and the other one at K s0.33av av
 .  .II-CL-b for both the control Fig. 6A and IGF-1-
 .treated cell layers Fig. 6B . Peak II-CL was submit-
ted to b-elimination to release single glycosamino-
glycan chains and rechromatographed on Superose 6
 .Fig. 6C and D . Peak II-CL-a shifted to K s0.33av
indicating that it was sensitive to b-elimination and
proving that it was PG in nature. On the contrary,
after alkaline treatment, peak II-CL-b eluted at the
same position as untreated peak and thus corre-
sponded to free GAG chains. Identical qualitative
 .results were obtained for control Fig. 6C and IGF-1
 .treated cultures Fig. 6D . In control cultures, the
w35 x  . w35 x ratio S -PG peak II-CL-a r S -GAG peak II-
.  .CL-b was approximately 0.65 Fig. 6C . Under IGF-1
 .  .conditions, this ratio increased 0.80 Fig. 6D since
IGF-1 stimulated production of PG but did not mod-
ify those of GAG which presumably represented
intracellular degradation products of internalized PG.
w35 x w3 xComparison of the S r H ratio calculated in
control and IGF-1 treated cultures indicated that IGF-1
w35 xinduced a 20 and 25% decrease in the relative S
 .incorporation in peak II-CL-a PG and peak II-CL-b
 .  .GAG , respectively Fig. 6A and B . As observed
for medium PG, IGF-1 altered the sulfation of GAG
chains associated to cell layer.
Approximately 20% of PG from peak II-CL-a
were sensitive to chondroitinase ABC, representing
chondroitin sulfaterdermatan sulfate proteoglycans,
while 80% were degraded by nitrous acid and corre-
sponded to heparan sulfate proteoglycans, both in
 .control Fig. 7A and C and in IGF-1 treated cells
 . Fig. 7. Gel filtration chromatography of DEAE-Trisacryl purified peak II-CL Fig. 3C and D on Superose-6. Peak II-CL from control A
.  .  .  .and C or IGF-1 50 ngrml treated cell layer extract B and D was chromatographed after chondroitinase ABC digestion A and B or
 .  . w35 x  . w3 xafter nitrous acid degradation C and D . -‘-‘- : S radioactivity. -v-v- : H radioactivity.
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 .Fig. 7B and D and Table 1 . The level of undersulfa-
tion induced by IGF-1 was evaluated by the
w35 x w3 xS r H ratio calculated for CSPG and HSPG
 .from cell layer extract Table 1 .
In peak II-CL-b, 65% of GAG were chondroitin
sulfaterdermatan sulfate in nature, the remaining
 .35% being heparan sulfate Fig. 7A and C . These
percentages were not modified when IGF-1 was pre-
 .sent in peritubular cell cultures Fig. 7B and D .
3.4. Effects of IGF-1 on PG and GAG synthesis
( )under para-nitrophenyl-b-D-xyloside PNPX condi-
tions
In preliminary experiments, we observed that
PNPX decreased the total PG synthesis in peritubular
cells and dramatically stimulated PNPX-primed GAG
production, in a time and dose-dependent manner.
The maximum effect of PNPX was reached 24 h after
addition of this exogeneous acceptor used at 1 mM
 .data not shown . 1 mM PNPX reduced by 60% the
w3 x  .H -glucosamine incorporation in PG Fig. 8A and
w3 xat the same time, increased by 150% the H -label-
 .ing in PNPX-GAG Fig. 8B .
In order to test the specificity of PNPX upon
peritubular cell PG and GAG synthesis, additional
experiments were conducted with para-nitro-b-D-
 .galactoside PNPG , a structural analog of PNPX,
w xdescribed as ineffective on PG synthesis 24 . The
addition of increasing concentrations of PNPG
 .0.01–1 mM to peritubular cell cultures remained
unchanged both PG and GAG basal synthesis data
.not shown .
Cells were simultaneously incubated with IGF-1
and PNPX, then PG and GAG production was as-
sessed. As presentated above and confirmed in Fig.
8A, in the absence of PNPX, IGF-1 increased PG
synthesis. When PNPX and IGF-1 were added in
w3 xassociation, the H -glucosamine incorporation in
 .PG appeared significantly enhanced Fig. 8A . This
result indicated that IGF-1 favored the glycosylation
of xylosylated core proteins which accumulated in
the cell because of the presence of PNPX. The basal
level of cellular GAG was not affected by IGF-1
 .treatment Fig. 8B but this factor increased by 30%
the synthesis of GAG formed on xyloside primer
 .Fig. 8B . If IGF-1 enhanced the fixation of glycanic
chains both on available core proteins and on PNPX,
 .  .Fig. 8. Effect of IGF-1 on the total synthesis of PG B, left and GAG diagonally striped area, right under para-nitrophenyl-xyloside
 .  .PNPX, 1 mM and cycloheximide CHX, 20 mM conditions. Confluent peritubular cells were incubated in culture medium,
 .supplemented or not with IGF-1 50 ngrml , in the absence or presence of PNPX and CHX used alone or in combination and double
w35 x w3 x labeled with S -sulfate and H -glucosamine. After 24 h of labeling, the synthesis of total PG and total GAG mediumqcell layer
. w3 xextract was determined as indicated in Section 2. Only results concerning H incorporation were shown. Similar results were obtained
w35 x  .with S labeling but with a lesser extent due to the IGF-1 induced undersulfation of GAG chains see Table 1 . Values are
means"SEM from 4 wells in 3 separated experiments. )P-0.05, ))P-0.01, )))P-0.001 when compared to their respective
control. NS: not significant.
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this effect may result from an increase of glycosyl-
transferase activities andror from an increase of de
no˝o synthesis of these enzymes. To test these possi-
bilities, cycloheximide, an inhibitor of protein synthe-
sis, was used under PNPX conditions. When cyclo-
heximide was introduced conjointly with PNPX, the
 .stimulatory effects of IGF-1 on PG Fig. 8A and on
 .PNPX-GAG Fig. 8B were suppressed. These results
suggested that IGF-1 exerted its action through the
synthesis of proteins involved, directly or indirectly,
in the glycosylation process.
3.5. Effects of tyrosine kinase inhibitors on IGF-1
stimulated PG synthesis
The action of two specific protein-tyrosine kinase
w x w xinhibitors, genistein 25 and tyrphostin A9 26 , on
IGF-1-stimulated PG synthesis was examined. From
8 to 80 mM, genistein did not significantly modify
w3 xbasal synthesis of total H -labeled proteoglycans
 .mediumqcell layer but counteracted the stimulat-
 .ing effect of IGF-1 Fig. 9A . Similarly, tyrphostin
A9 used at concentrations ranging from 0.025 to 0.4
mM did not change the basal synthesis of proteogly-
cans and at 0.2 mM abolished IGF-1 stimulation
 .Fig. 9B . To rule out a non-specific activity of these
inhibitors, daidzein, an inactive analog of genistein
and tyrphostin A1 an inactive inhibitor used as nega-
tive control for tyrphostin A9 were tested. In pres-
 . ence of daidzein Fig. 9A and tyrphostin A1 Fig.
.9B , the extent of increase in proteoglycan synthesis
due to IGF-1 remained unchanged. In these experi-
ments, identical results were obtained when PG were
w35 x  .labeled with S -sulfate data not shown .
4. Discussion
In the present work, we have examined the regula-
tion of peritubular cell PG synthesis by IGF-1, which
is a growth factor widely produced in the rat testis
w x8 . We have found that IGF-1 enhanced the synthesis
w35 xof the PG, visualized by the S -sulfate and the
w3 xH -D-glucosamine incorporations by peritubular
cells, in a time and dose-dependent manner. Since a
wide variety of cell types demonstrate a mitogenic
w xresponse to IGF-1 27 and though the cells were
used at confluence, a possible effect of IGF-1 on cell
proliferation was not excluded. Indeed, IGF-1 did not
modify the DNA content of the cell layer in our
experimental conditions, proving that its action did
not occur through cell proliferation. Pulse-chase ex-
periments showed that the increased content of PG
found in peritubular cells in the presence of IGF-1
Fig. 9. Effect of genistein and tyrphostin A9 on the IGF-1 stimulated PG synthesis. Confluent peritubular cells were pretreated with
 .  .  . increasing concentrations of genistein A, left or tyrphostin A9 B, right for 30 min. Then, IGF-1 50 ngrml was introduced hatched
.  . w35 x w3 xbars or not open bars and cell cultures were labeled with S -sulfate and H -glucosamine. After 24 h of labeling, the synthesis of
total PG was determined. Daidzein and tyrphostin A1 are used as negative control for genistein and tyrphostin A9 respectively. Only
w3 x )results concerning H incorporation were shown. Values are means"SEM from 4 wells in 3 separated experiments. P-0.05,
))P-0.01, )))P-0.001 when compared to their respective control. NS: not significant. G: genistein, D: daidzein, A9: tyrphostin A9,
A1: tyrphostin A1.
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 .50 ngrml for 24 h was the result of an enhance-
ment of PG synthesis rather than a decreased rate of
degradation. The rate of PG which disappeared in the
cell layer corresponded to an apparent t of 11 and1r2
w35 x24 h when estimated after prelabeling with S -
w3 xsulfate and H -D-glucosamine, respectively. Since
w3 xthe H -D-glucosamine labeling reflected the PG
w35 xamount while the S -sulfate labeling reflected the
PG sulfation, it might be deduced that a desulfation
process occurred before the release of PG from the
cell layer, whatever the conditions with or without
.IGF-1 .
This enhancement of PG synthesis in the presence
of IGF-1 has already been reported with other cell
w xtypes such as glomerular cells 28 , flexor tendon
w x w xcells 29 , mesangial cells 30 and particularly chon-
drocytes which have received much attention. In the
last cell type, IGF-1 stimulated the synthesis of ag-
grecan whose physical and chemical characteristics
w xwere similar to the control 10 . In order to examine
if IGF-1 could act in the same manner in our cell
model, the hydrodynamic sizes of the proteoglycans
secreted in the medium and associated to the cell
layer as well as the nature of their GAG were studied.
In peritubular cell cultures, IGF-1 stimulated the
proteoglycan synthesis from the medium and cell
layer but did not alter the proteochondroitin
sulfaterproteoheparan sulfate distribution in these
two compartments. The biosynthesis of proteogly-
cans, such as proteochondroitin sulfate and proteo-
heparan sulfate, is a complicated process which con-
sists of sequential formation of the core protein,
xylosylation of specific serine residues of the core
protein, elaboration of the tetrasaccharide protein-
glycosaminoglycan linkage moiety, repeated addition
of hexosamine residues alternating with glucuronic
acid residues to form the large polymer glycosamino-
glycan chains, additional modifications of these
glycosaminoglycan chains O-sulfation, deacetyla-
tionrN-sulfation, epimerization of glucuronic acid to
. w xiduronic acid 31,32 . Proteoglycan biosynthesis may
be dependent on the regulation of several steps of this
w3 xprocess. IGF-1 increased incorporation of H -
w35 xhexosamine and in lesser extent those of S -sulfate
in glycosaminoglycan chains of peritubular cell pro-
teoglycans. So, b-xyloside was used in order to test
the effect of IGF-1 on proteoglycan glycosylation.
b-xyloside act as exogenous acceptor for the addition
of the first linkage region galactose by galactosyl
transferase I. This diverts glycosaminoglycan chain
elongation from the xylosylated core protein onto the
exogenous xyloside and under these conditions, the
availability of endogenous core proteins is not a
restrictive factor for the glycosaminoglycan synthesis
w x33 . When IGF-1 was added together with PNPX, it
w3 xenhanced H -hexosamine incorporation in the newly
synthesized glycosaminoglycans to an extent higher
than PNPX alone. At the same time, an increase in
w3 xH -labeling with identical magnitude was found for
the core protein pool. These observations indicated
that one of the effects of IGF-1 was to stimulate
glycosaminoglycan chain biosynthesis. Moreover, cy-
cloheximide suppressed the IGF-1 effects suggesting
that this factor could enhance glycosaminoglycan
 .production by induction of glycosytransferase s . In
our work, IGF-1 modified neither the GAG chain
length, nor the PG molecular weight. The most plau-
sible explanation is that IGF-1 initially enhances the
number of newly synthesized PG, whose character-
istics remain unchanged. This phenomenon may re-
sult from an increase in core protein pool glycosyla-
tion, but we do not rule out that IGF-1 may also
stimulate the expression of core proteins concomitant
with those of glycosyltransferases. Further investiga-
tions are necessary to clarify this point.
In the presence of IGF-1, proteoglycan from the
medium and cell layer appeared undersulfated, the
w35 x w3 xratio S -sulfater H -hexosamine decreasing by
20–25% in heparan sulfate and chondroitin sulfate
chains. Interestingly, similar changes in glycosamino-
glycan sulfation were reported in vascular endothelial
w xcells, smooth-muscle cells and fibroblasts 34 after
treatment by bFGF. Sulfation involves the activation
of inorganic sulfate as adenosine 3X-phosphate 5X
 .phosphosulfate PAPS and the subsequent transfer of
the ‘active sulfate’ by specific sulfotransferases. It is
generally accepted that sulfation occurs at the same
time as, or immediately after glycosaminoglycan
w xchain elongation 31,32 . Although sugar-chain for-
mation and sulfation are spatially and temporally
related, these two processes may be, at least in part,
differentially affected by IGF-1 and bFGF but at
present, the causes of this imbalance are not defined.
w35 x w3 xDespite the half-life of S and H -labeled PG
being highly different, it is unlikely that, after GAG
chain catabolism, the difference in the re-use of
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w35 x w3 xS -sulfate and H -hexosamine may explain un-
dersulfation. Since the PAPS pool is small and the
intracellular sulfate pool is rapidly equilibrated with
 .the exogenous sulfate 0.4 M in our culture medium ,
w35 xisotopic dilution of S -sulfate is considerable and
w35 xwill remain practically constant even if S -sulfate
w3 xis re-used. Similarly, the specific activity of H in
the metabolic hexosamine pool is often several hun-
w3 xdred-fold lower than that of the H -glucosamine
added to the cell culture medium due to a large
contribution of glucose to the intracellular UDP-N-
w xacetylhexosamine pool 35 .
The cell surface receptor for IGF-1 is composed of
two a- and two b-subunits. Whereas the a-subunits
contain ligand-binding domains, the cytoplasmic do-
main of the b-subunits possess tyrosine kinase activ-
w xity that is required for cellular signaling 36 . IGF-1
binding to the receptor results in activation of the
w xreceptor tyrosine kinase 37 and subsequent phos-
phorylation of both the receptor and intracellular
substrate proteins that are direct substrates of the
IGF-1 receptor kinase such as the insulin receptor
 . w x w xsubstrate-1 IRS-1 38 and the Shc proteins 39 .
Since genistein and tyrphostin A9, two potent and
specific inhibitors of tyrosine kinase, totally abol-
ished IGF-1-induced PG synthesis stimulation, we
suggest that genistein and tyrphostin A9-sensitive
putative tyrosine kinases are involved in the signal
transduction pathways mediating the action of IGF-1
on PG production. In peritubular cell cultures, we
have found that IGF-1 enhanced hyaluronic acid pro-
duction approximately two fold. Hyaluronic acid syn-
thesis depends on a plasma membrane-bound en-
w xzyme, the hyaluronate synthetase 40,41 . Phosphory-
lation of synthetase was required for activity and
w xmultiple kinases could phosphorylate it 42 among
them the tyrosine kinase of pp60src from Rous sar-
w xcoma virus 23 . Previous work showed that genistein
pretreatment inhibited IGF-1-induced hyaluronic acid
w xsynthesis and hyaluronate syntethase activity 43 .
This, therefore, raised the possibility that the IGF-1
stimulation of hyaluronic acid synthesis, in our model,
might also be triggered by protein tyrosine kinase
activation.
The physiological significance of the modifications
induced by IGF-1 on proteoglycan biosynthesis and
particularly the undersulfation is still unknown. It has
been shown that the biological activity of IGF-1 is
 . w xmodified by IGF-binding proteins IGFBPs 44 , the
binding of IGF-1 to the cell surface or extracellular
matrix associated IGFBPs resulting in potentiation of
w xcellular actions of this growth factor 45,46 . IGFBP-
w x2, mainly produced by peritubular cells 7 , interacted
with glycosaminoglycans, such as heparan sulfate, in
which the presence of O-linked sulfate groups in the
2 or 3 position of the iduronic acid ring was essential
w xfor the binding 47 . Thus, the reduction in sulfation
of heparan sulfate could result in a decrease in the
heparan sulfate-IGFBP-2 binding and consequently in
a lower IGF-1 activity, constituting a short negative
local regulatory loop. It has also been shown that
proteoglycans, mainly proteoheparan sulfate, serve as
tissue stores or carrier systems for a large variety of
important effector molecules and are implicated in
receptor-growth factor interactions, in cell–cell
recognition systems and in cell–matrix adhesion pro-
w xcesses 48,49 . Within glycosaminoglycan chains,
 .  .saccharide sequence s of defined structure is are
w xrequired to specifically bind one particular ligand 32
and alterations in these sequences can disturb the
binding. In testis, the multiple interactions between
peritubular cells and Sertoli cells is of importance to
preserve the structural and functional integrity of
w xseminiferous tubules 50 . The undersulfation induced
by IGF-1 of proteoglycans synthesized by peritubular
cells could modify their influence on Sertoli cells and
thus represent an additional control mechanism.
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